Archive for the ‘Diabetes Medications’ Category

Type 1 Diabetics Respond Well to New Type 2 Diabetes Medication

Friday, August 12th, 2011

Diabetes medication

Type 1 diabetics given a recently approved type 2 diabetes medication in addition to their insulin therapy experienced a “dramatic change” in their health. They had more stable blood sugar levels, needed less insulin, and even lost an average ten pounds over six months.

The FDA approved Victoza as a once-daily injection to treat type 2 non insulin dependent diabetes in adults in early 2010.  Although it is injected, Victoza is not a type of insulin.  Victoza (generic name liraglutide) belongs to a new class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists.
(more…)

Share

FDA Approves New Type 2 Diabetes Medication

Monday, June 13th, 2011

DPP-4 Inhibitor

The FDA has approved a new oral diabetes medication, Tradjenta (linagliptin) to help control blood glucose in type 2 diabetics. Tradjenta works by blocking the enzyme dipeptidyl peptidase-4 (DPP-4), resulting in increased levels of hormones which stimulate the release of insulin after eating.

Tradjenta was tested in almost 4000 diabetics in eight separate double-blind clinical studies. It was studied both by as a stand-alone therapy, and in combination with other current diabetes medications such as glimepiride, pioglitazone, and metformin. It has not been tested along with insulin injections, and is not recommended for use by insulin dependent type 1 diabetics.

Tradjenta is meant to be used along with diet and exercise. People with diabetic ketoacidosis (high levels of ketones in the blood or urine) are cautioned not to use linagliptin. People taking the antibiotic rifampin, used to treat tuberculosis, should also avoid Tradjenta. The most common side effects of linagliptin were nasal congestion or a runny nose, sore throat, upper respiratory infection headache, and muscle pain.
(more…)

Share

Buy Humalog Insulin Lispro for Effective Diabetes Care

Monday, April 4th, 2011

The international community has approved Humalog Vial 10 ml for the treatment of type 1 diabetes. It has become vital to treat type 1 diabetes properly. Did you know that Canada in number six in the world in terms of the number of children under the age of 14 years getting type 1 diabetes.

The disease is an autoimmune ailment that is not preventable. It has not been determined yet how it starts and why it affects children, more than adults, but we know is that the body’s immune system starts malfunctioning and destroys insulin-producing cells in the pancreas. The bad news is that this type of diabetes leaves patients dependent on insulin for life.
(more…)

Share

Diabetics At Risk Of Diabetic Retinopathy Warns Big Mountain Pharmacy

Friday, January 14th, 2011

Diabetes sufferers often experience other complications in the body caused by their diabetes. One of the complications that may arise is diabetic retinothapy, which is also known as diabetic blindness.

The Symptoms of Diabetic Retinopathy
High blood glucose levels can often cause damage to the blood vessels that supply oxygen and chemicals to the retina in the eye if diabetics do not manage their condition sufficiently. Diabetic retinopathy is the name given to the condition when the blood vessels to the retina thin due to the wall of the vessels becoming thicker. A common symptom that might be noticed by a patient is a change in sight caused by liquid seeping into the retina. This causes swelling and eventually causes blurry vision, which is exacerbated over time. (more…)

Share

Common Diabetes Medication Shown to Fight Cancer

Sunday, September 19th, 2010

A widely used diabetes medication, metformin, may inhibit or prevent the growth of cancer cells. Interest in metformin’s possible cancer –fighting properties first arose in 2005, when British researchers noticed that diabetics taking the diabetes drug had a 40% lower cancer risk. Several follow-up studies made the same finding, with the risk reduction ranging from 30 to 70 percent depending on the type of cancer.

A recent study conducted at the National Cancer Institute found that mice given oral metaformin developed between 40 and 50 percent fewer tumors when exposed to a common carcinogen in cigarettes, while mice injected with the anti-diabetic medication had 72 percent fewer tumors. (more…)

Share

DPP-4 Inhibitors Help Diabetics to Control Blood Sugar

Friday, July 2nd, 2010

Almost 24 million American adults and children (about eight percent of population) have diabetes. Diabetes is the sixth leading cause of death in the US, down from the fifth leading cause in 2007. Type 2 diabetes (also known as non-insulin dependent diabetes) is the most common form of the disease. Ninety to ninety-five percent of diabetics have type 2 diabetes.

In type 2 diabetes, either the body does not produce enough insulin, or the body’s cells ignore the insulin that is produced. The result is high blood sugar levels, which increases the risk of heart disease, blindness, circulation problems and nerve and kidney damage. Type 2 diabetes is treated (more…)

Share